4/16
04:37 pm
pfe
ACIP Votes to Expand Recommendation for Pfizer's RSV Vaccine ABRYSVO® to Include Adults Aged 50 to 59 at Increased Risk of Disease [Yahoo! Finance]
Low
Report
ACIP Votes to Expand Recommendation for Pfizer's RSV Vaccine ABRYSVO® to Include Adults Aged 50 to 59 at Increased Risk of Disease [Yahoo! Finance]
4/16
04:15 pm
pfe
ACIP Votes to Expand Recommendation for Pfizer’s RSV Vaccine ABRYSVO® to Include Adults Aged 50 to 59 at Increased Risk of Disease
Low
Report
ACIP Votes to Expand Recommendation for Pfizer’s RSV Vaccine ABRYSVO® to Include Adults Aged 50 to 59 at Increased Risk of Disease
4/14
09:34 pm
pfe
Pfizer ends development of potential pill obesity treatment [CNN]
Low
Report
Pfizer ends development of potential pill obesity treatment [CNN]
4/14
09:28 pm
pfe
Pfizer ends development of potential pill obesity treatment [CNN]
Low
Report
Pfizer ends development of potential pill obesity treatment [CNN]
4/14
01:00 pm
pfe
Pfizer Inc. (PFE): “Dead Money… Close the Casket,” Says Jim Cramer [Yahoo! Finance]
Low
Report
Pfizer Inc. (PFE): “Dead Money… Close the Casket,” Says Jim Cramer [Yahoo! Finance]
4/14
10:56 am
pfe
Drug Discovery Market Size to Rise USD 160.31 Billion by 2034 | Statifacts [Yahoo! Finance]
Low
Report
Drug Discovery Market Size to Rise USD 160.31 Billion by 2034 | Statifacts [Yahoo! Finance]
4/14
10:31 am
pfe
Is Pfizer Inc. (PFE) Among the Best Dividend Paying Stocks According to Hedge Funds? [Yahoo! Finance]
Low
Report
Is Pfizer Inc. (PFE) Among the Best Dividend Paying Stocks According to Hedge Funds? [Yahoo! Finance]
4/14
09:56 am
pfe
Pfizer discontinues GLP-1 pill trial, stock trades flat [Yahoo! Finance Canada]
Low
Report
Pfizer discontinues GLP-1 pill trial, stock trades flat [Yahoo! Finance Canada]
4/14
08:57 am
pfe
Pfizer ends development of potential pill obesity treatment [Globe and Mail, The (Toronto, Canada)]
Low
Report
Pfizer ends development of potential pill obesity treatment [Globe and Mail, The (Toronto, Canada)]
4/14
08:51 am
pfe
Pfizer ends development of potential pill obesity treatment [Yahoo! Finance]
Low
Report
Pfizer ends development of potential pill obesity treatment [Yahoo! Finance]
4/14
06:45 am
pfe
Pfizer Provides Update on Oral GLP-1 Receptor Agonist Danuglipron
Low
Report
Pfizer Provides Update on Oral GLP-1 Receptor Agonist Danuglipron
4/13
06:02 am
pfe
Kennedy's hypocritical approach to public health puts us all at risk [Los Angeles Times (CA)]
Low
Report
Kennedy's hypocritical approach to public health puts us all at risk [Los Angeles Times (CA)]
4/11
08:22 pm
pfe
Pfizer (PFE) Advances But Underperforms Market: Key Facts [Yahoo! Finance]
Low
Report
Pfizer (PFE) Advances But Underperforms Market: Key Facts [Yahoo! Finance]
4/11
11:03 am
pfe
Antibody Discovery Market Size to Achieve USD 22,570 Mn by 2034 | Statifacts [Yahoo! Finance]
Low
Report
Antibody Discovery Market Size to Achieve USD 22,570 Mn by 2034 | Statifacts [Yahoo! Finance]
4/10
11:00 am
pfe
Pfizer Invites Shareholders to Attend Virtual 2025 Annual Meeting of Shareholders on April 24
Low
Report
Pfizer Invites Shareholders to Attend Virtual 2025 Annual Meeting of Shareholders on April 24
4/10
10:59 am
pfe
Pfizer Stock Falls to New 52-Week Low: Should You Buy the Dip? [Yahoo! Finance]
Low
Report
Pfizer Stock Falls to New 52-Week Low: Should You Buy the Dip? [Yahoo! Finance]
4/9
08:14 pm
pfe
Is Pfizer (NYSE:PFE) A Risky Investment? [Yahoo! Finance]
Medium
Report
Is Pfizer (NYSE:PFE) A Risky Investment? [Yahoo! Finance]
4/8
05:52 pm
pfe
Pfizer Inc. (NYSE: PFE) had its price target lowered by analysts at UBS Group AG from $28.00 to $24.00. They now have a "neutral" rating on the stock.
Low
Report
Pfizer Inc. (NYSE: PFE) had its price target lowered by analysts at UBS Group AG from $28.00 to $24.00. They now have a "neutral" rating on the stock.
4/8
12:21 pm
pfe
Pfizer Inc. (NYSE: PFE) had its "neutral" rating re-affirmed by analysts at The Goldman Sachs Group, Inc.. They now have a $25.00 price target on the stock, down previously from $32.00.
Low
Report
Pfizer Inc. (NYSE: PFE) had its "neutral" rating re-affirmed by analysts at The Goldman Sachs Group, Inc.. They now have a $25.00 price target on the stock, down previously from $32.00.
4/4
11:05 am
pfe
Pfizer Inc. (PFE) – Jim Cramer Declares: ‘Dead Money – Close the Casket!' [Yahoo! Finance]
Low
Report
Pfizer Inc. (PFE) – Jim Cramer Declares: ‘Dead Money – Close the Casket!' [Yahoo! Finance]
4/3
08:12 am
pfe
Community Acquired Pneumonia Research Report 2025: Market Expected to Reach USD 3.09 Billion by 2032 - Explore the Impact of Combination Therapies and Diagnostic Advances [Yahoo! Finance]
Low
Report
Community Acquired Pneumonia Research Report 2025: Market Expected to Reach USD 3.09 Billion by 2032 - Explore the Impact of Combination Therapies and Diagnostic Advances [Yahoo! Finance]
4/3
08:03 am
pfe
Pfizer Inc. (NYSE: PFE) had its "neutral" rating re-affirmed by analysts at Citigroup Inc..
Low
Report
Pfizer Inc. (NYSE: PFE) had its "neutral" rating re-affirmed by analysts at Citigroup Inc..
4/2
07:46 pm
pfe
Pfizer (PFE) Increases Yet Falls Behind Market: What Investors Need to Know [Yahoo! Finance]
Low
Report
Pfizer (PFE) Increases Yet Falls Behind Market: What Investors Need to Know [Yahoo! Finance]
4/1
08:56 pm
pfe
Pfizer (NYSE:PFE) Expands RSV Vaccine Use In Europe Amid 3% Share Price Dip [Yahoo! Finance]
Low
Report
Pfizer (NYSE:PFE) Expands RSV Vaccine Use In Europe Amid 3% Share Price Dip [Yahoo! Finance]
4/1
08:56 pm
pfe
Why Major Pharmaceutical Stocks Tumbled on Tuesday [Yahoo! Finance]
Low
Report
Why Major Pharmaceutical Stocks Tumbled on Tuesday [Yahoo! Finance]